跳至主要内容
临床试验/NCT00016458
NCT00016458已完成2 期

Phase II Pilot Study of Cyclophosphamide and Rabbit Anti-Thymocyte Globulin as Salvage Therapy in Patients With Diffuse Systemic Sclerosis

Fred Hutchinson Cancer Center6 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2000年6月最近更新:
适应症
相关药物

试验速览

阶段
2 期
状态
已完成
入组人数
20
试验地点
6

研究概览

简要总结

OBJECTIVES: I. Determine the toxicity of cyclophosphamide and rabbit anti-thymocyte globulin in patients with diffuse systemic sclerosis.

II. Determine the efficacy of this regimen in terms of controlling disease in these patients.

详细描述

PROTOCOL OUTLINE: Patients receive cyclophosphamide IV over 1-2 hours on day 1 and rabbit anti-thymocyte globulin IV over 6-8 hours on days 2-5.

Patients are followed on days 60-85 and then every 3 months for 1 year.

研究设计

研究类型
Interventional
主要目的
Treatment

入排标准

年龄范围
— 至 64 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

研究者

申办方类型
Other

研究点 (6)

Loading locations...

相似试验

已完成
2 期
Cyclophosphamide Versus Anti-thymocyte Globulin for GVHD Prophylaxis After RIC Allo-SCTGraft vs Host Disease
NCT02876679Assistance Publique - Hôpitaux de Paris94
已完成
2 期
Cyclophosphamide and Anti-thymocyte Globulin Followed By Methotrexate and Cyclosporine in Preventing Chronic Graft-Versus-Host Disease in Patients With Severe Aplastic Anemia Undergoing Donor Bone Marrow TransplantAplastic Anemia
NCT00343785Fred Hutchinson Cancer Center21
已完成
2 期
Scleroderma Treatment With Autologous Transplant (STAT) StudySystemic Scleroderma
NCT01413100Fred Hutchinson Cancer Center21
已完成
1 期
Vaccine Therapy and Cyclophosphamide in Treating Patients With Stage II-III Breast or Stage II-IV Ovarian, Primary Peritoneal, or Fallopian Tube CancerRecurrent Breast CarcinomaRecurrent Fallopian Tube CarcinomaRecurrent Ovarian CarcinomaRecurrent Primary Peritoneal CarcinomaStage IIA Breast CancerStage IIA Fallopian Tube CancerStage IIA Ovarian CancerStage IIB Breast CancerStage IIB Fallopian Tube CancerStage IIB Ovarian CancerStage IIC Fallopian Tube CancerStage IIC Ovarian CancerStage IIIA Breast CancerStage IIIA Fallopian Tube CancerStage IIIA Ovarian CancerStage IIIA Primary Peritoneal CancerStage IIIB Breast CancerStage IIIB Fallopian Tube CancerStage IIIB Ovarian CancerStage IIIB Primary Peritoneal CancerStage IIIC Breast CancerStage IIIC Fallopian Tube CancerStage IIIC Ovarian CancerStage IIIC Primary Peritoneal CancerStage IV Fallopian Tube CancerStage IV Ovarian CancerStage IV Primary Peritoneal Cancer
NCT01606241Mayo Clinic24
已完成
2 期
Anti-thymocyte Globulin and Cyclosporine as First-Line Therapy in Treating Patients With Severe Aplastic AnemiaAplastic Anemia
NCT01231841The Cleveland Clinic20